Alto Neuroscience, Inc.

NYSE:ANRO

Pharmaceutical Preparations·MOUNTAIN VIEW, CA

The musical term alto, meaning "high" in Italian, historically refers to the contrapuntal part higher than the tenor and its associated vocal range. In four-part voice leading alto is the second-highest part, sung in choruses by either low women's or high men's voices.

CEO

Etkin Amit

CFO

Smith Nicholas Conrad

Financials

8 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/12/25	→
10-Q	Q2 2025	6/30/25	8/13/25	→
10-Q	Q1 2025	3/31/25	5/14/25	→
10-K	FY 2024	12/31/24	3/20/25	→
10-Q	Q3 2024	9/30/24	11/12/24	→
10-Q	Q2 2024	6/30/24	8/13/24	→
↓

Earnings Releases (8-K)

9 shown

Filed	Period
11/12/25	Q4 FY2025	→
8/13/25	Q3 FY2025	→
5/14/25	Q2 FY2025	→
3/20/25	Q1 FY2025	→
2/3/25	Q1 FY2025	→
11/12/24	Q4 FY2024	→
↓

News (8-K)

11 shown

Filed	Type	Description
10/20/25	Agreement	Entry into a Material Definitive Agreement	→
7/8/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
6/26/25	Other	Other Events	→
6/3/25	Agreement	Entry into a Material Definitive Agreement	→
2/12/25	Other	Other Events	→
1/16/25	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

10 shown

Filed	Form	Description
11/28/25	S-3	S-3	→
4/1/25	ARS	ARS	→
3/20/25	S-8	S-8	→
2/3/25	S-3	S-3	→
2/6/24	S-8	S-8	→
2/5/24	424B4	424B4	→
↓

Filing History(152 filings)

TypeDateAccessionPeriodSize

Mar 3, 2026

0002007795-26-000002FORM 4

Mar 1, 2026

4.9 KB

Mar 3, 2026

0002009130-26-000002FORM 4

Mar 1, 2026

4.9 KB

SCHEDULE 13G/A

Feb 18, 2026

0001172661-26-001305

—

10.2 KB

SCHEDULE 13G/A

Feb 17, 2026

0001172661-26-001262

—

10.2 KB

SCHEDULE 13G/A

Feb 17, 2026

0000905148-26-000894

—

11.5 KB

SCHEDULE 13G/A

Feb 17, 2026

0000902664-26-001136

—

17.2 KB

SCHEDULE 13G/A

Feb 17, 2026

0001831942-26-000005

—

15.2 KB

SCHEDULE 13G

Feb 17, 2026

0000902664-26-001074

—

14.5 KB

SCHEDULE 13G/A

Feb 17, 2026

0001193125-26-054522

—

11.5 KB

Feb 13, 2026

0002007795-26-000001FORM 4

Feb 11, 2026

5.4 KB

Feb 13, 2026

0002008707-26-000001FORM 4

Feb 11, 2026

5.4 KB

Feb 13, 2026

0002009130-26-000001FORM 4

Feb 11, 2026

5.4 KB

Feb 13, 2026

0001791413-26-000001FORM 4

Feb 11, 2026

5.4 KB

Jan 6, 2026

0002008499-26-000002FORM 4

Jan 2, 2026

5.7 KB

Jan 6, 2026

0002008212-26-000002FORM 4

Jan 2, 2026

5.7 KB

Jan 6, 2026

0002009654-26-000002FORM 4

Jan 2, 2026

5.6 KB

Jan 6, 2026

0001830326-26-000002FORM 4

Jan 2, 2026

5.6 KB

EFFECT

Dec 10, 2025

9999999995-25-003645

—

1.7 KB

S-3

Nov 28, 2025

0001104659-25-116507S-3

—

741.1 KB

10-Q

Nov 12, 2025

0001999480-25-00009010-Q

Sep 30, 2025

8.4 MB

8-K

Nov 12, 2025

0001999480-25-0000898-K

Nov 12, 2025

230.3 KB

Oct 27, 2025

0001231919-25-000357

—

12.8 KB

SCHEDULE 13G

Oct 27, 2025

0001831942-25-000022

—

14.8 KB

8-K

Oct 20, 2025

0001104659-25-100801FORM 8-K

Oct 19, 2025

768.1 KB

SCHEDULE 13G

Oct 10, 2025

0001193125-25-236739

—

190.8 KB

25 filings shown

Alto Neuroscience, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(152 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
5/9/25	DEFR14A	DEFR14A	→
4/1/25	DEFA14A	DEFA14A	→
4/1/25	DEF 14A	DEF 14A	→

Filed	Form	Description
3/3/26	4	4	→
3/3/26	4	4	→
2/13/26	4	4	→
2/13/26	4	4	→
2/13/26	4	4	→
2/13/26	4	4	→
↓

Filed	Form	Description
2/18/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/17/26	SCHEDULE 13G	SCHEDULE 13G	→
↓